Cargando…
Window-of-Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker
PURPOSE: The anticancer activity of valproic acid (VPA) is attributed to the inhibition of histone deacetylase. We previously published the genomically derived sensitivity signature for VPA (GDSS-VPA), a gene expression biomarker that predicts breast cancer sensitivity to VPA in vitro and in vivo. W...
Autores principales: | Cohen, Adam L., Neumayer, Leigh, Boucher, Ken, Factor, Rachel E., Shrestha, Gajendra, Wade, Mark, Lamb, John G., Arbogast, Kylee, Piccolo, Stephen R., Riegert, Joanna, Schabel, Matthias, Bild, Andrea H., Werner, Theresa L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446454/ https://www.ncbi.nlm.nih.gov/pubmed/32913974 http://dx.doi.org/10.1200/PO.16.00011 |
Ejemplares similares
-
Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility
por: Piccolo, Stephen R, et al.
Publicado: (2016) -
Window of Opportunity
Publicado: (1996) -
Windows of opportunity for the peopling of the Americas
por: Lesnek, Alia J.
Publicado: (2023) -
Window of opportunity trials in head and neck cancer
por: Farlow, Janice L., et al.
Publicado: (2019) -
COVID-19 – A window of opportunity for the transition toward sustainable mobility?
por: Schmidt, Karolin, et al.
Publicado: (2021)